CORONA REMEDIES LIMITED

Issue Date Price Band Bid Lot Registar BRLM
08 Dec, 2025 - 10 Dec, 2025 ₹ 1008 - 1062 14 shares & in multiples BIGSHARE JM, IIFL, KOTAK

Subscription Level As On : 10-Dec-2025 11:59:04 PM

Category Book Size Subscription
No. of Shares Offered Amount No. of Shares Bid Amount No. of Times
@ Upper @ Upper
QIB 12,23,202 1,29,90,40,524 35,89,39,448 3,81,19,36,93,776 293.44
NII 9,17,403 97,42,81,986 20,18,97,066 2,14,41,46,84,092 220.07
NII (Above 10 lacs) 6,11,602 64,95,21,324 15,07,93,356 1,60,14,25,44,072 246.55
NII (2-10 lacs) 3,05,801 32,47,60,662 5,11,03,710 54,27,21,40,020 167.11
Retail 21,40,606 2,27,33,23,572 6,48,02,080 68,81,98,08,960 30.27
Employee 58,035 6,16,33,170 9,02,888 95,88,67,056 15.56
Total 43,39,246 4,60,82,79,252 62,65,41,482 6,65,38,70,53,884 144.39
www.ognajwala.in Applications : 27,89,337 (18.24)

Chirag Shah (Ognajwala)

Disclaimer: The above-mentioned information/data are sourced from the websites of the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on a real-time basis. For updated information/data, you can visit their respective website. The information/data provided herein above are for information purposes only and provided by Ognajwala.in on an "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. Ognajwala.in does not guarantee or warrant the accuracy, adequacy, or completeness of the information received through the said websites. Ognajwala.in holds no responsibility of any kind as regards any discrepancies, errors, omissions, losses, or damages. Ognajwala.in including its affiliates and any of its officers, directors, personnel, and employees, shall not be liable for any loss, or damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information/data received through the said websites. The recipient alone shall be fully responsible/liable for any decision taken based on such information/data. All recipients should before acting upon the said information make their investigation, and seek appropriate professional advice.